SLC6A4 Recombinant Monoclonal Antibody

Code CSB-RA224413A0HU
Size US$210
Order now
Image
  • Western Blot
    Positive WB detected in: U-87 whole cell lysate, 293T whole cell lysate, U-251 whole cell lysate, HepG2 whole cell lysate
    All lanes: Serotonin transporter antibody at 1:1000
    Secondary
    Goat polyclonal to rabbit IgG at 1/50000 dilution
    Predicted band size: 71, 75 kDa
    Observed band size: 55 kDa
  • IHC image of CSB-RA224413A0HU diluted at 1:100 and staining in paraffin-embedded human testis tissue performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4℃ overnight. The primary is detected by a Goat anti-rabbit IgG polymer labeled by HRP and visualized using 0.05% DAB.
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
SLC6A4
Alternative Names
Sodium-dependent serotonin transporter (SERT) (5HT transporter) (5HTT) (Solute carrier family 6 member 4), SLC6A4, HTT SERT
Species Reactivity
Human
Immunogen
A synthesized peptide derived from human Serotonin transporter
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated
Clonality
Monoclonal
Isotype
Rabbit IgG
Clone No.
9G3
Purification Method
Affinity-chromatography
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Form
Liquid
Tested Applications
ELISA, WB, IHC
Recommended Dilution
Application Recommended Dilution
WB 1:500-1:5000
IHC 1:50-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Description

The creation of the SLC6A4 recombinant monoclonal antibody involves four main stages: sequencing the SLC6A4 monoclonal antibody gene, cloning the gene into a plasmid vector, introducing the recombinant vector into a host cell line, and purifying the SLC6A4 recombinant monoclonal antibody using affinity chromatography. The SLC6A4 monoclonal antibody is obtained from the SLC6A4 antibody-producing hybridomas, with a synthesized peptide derived from human SLC6A4 used as the immunogen during its production. Once purified, the SLC6A4 recombinant monoclonal antibody is then tested and characterized and can be utilized in ELISA, WB, and IHC applications to detect human SLC6A4 protein.

The SLC6A4 protein, also known as the serotonin transporter (SERT), is a membrane-bound protein that plays a key role in the regulation of serotonin neurotransmission in the brain. SLC6A4 is responsible for the reuptake of serotonin from the synaptic cleft back into the presynaptic neuron, thereby terminating the action of serotonin at the synapse. This process is important in the modulation of mood, behavior, and various physiological processes. Dysfunction of the SLC6A4 gene has been associated with various psychiatric disorders, including depression, anxiety, and autism.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Serotonin transporter whose primary function in the central nervous system involves the regulation of serotonergic signaling via transport of serotonin molecules from the synaptic cleft back into the pre-synaptic terminal for re-utilization. Plays a key role in mediating regulation of the availability of serotonin to other receptors of serotonergic systems. Terminates the action of serotonin and recycles it in a sodium-dependent manner.
Gene References into Functions
  1. platelet 5-HT content and SERT as peripheral surrogates in depression and anxiety patients PMID: 30031795
  2. The relationship between bullying and pain was modified by genetic variation in the promotor region of SLC6A4. Study data indicated that the effect of bullying on health and well-being is dependent on a gene-environment interaction. PMID: 29313869
  3. This study showed an interaction exists in which the S allele of 5-HTTLPR increases risk of depression only in stressed individuals. PMID: 28373689
  4. STin2 VNTR polymorphism of SLC6A4 gene may contribute to Crohn's disease pathogenesis. PMID: 30394015
  5. 5HTTLPR and dating violence victimization interact to increase odds of marijuana use. PMID: 30049530
  6. ECs derived miR-195 acts as a new regulator to modulate the expression of 5-HTT in SMCs. PMID: 28272473
  7. rs591323 had the effect on SERT availability of pons in healthy male subjects, not in female subjects. SERT availability of AA genotype of rs591323 was lower than those of the other 2 genotypes. However, SNPs of risk loci for Parkinson's disease did not show any effect on DAT availability. PMID: 29774458
  8. platelet BDNF and SERT do not specifically underlie psychosocial deficits in stage Huntington's Disease PMID: 30039833
  9. SLC6A4 l/l carriers have a better ability to perceive and focus their attention on the elements of their environment and to have the capacity to understand and predict what will happen with those elements. PMID: 29298559
  10. 5-HTTLPR's variant moderates Adolescent Substance Misuse Initiation. PMID: 27861757
  11. High serotonin and SERT levels may indicate that these biomarkers have a role in the autism pathogenesis and support the possibility of using serotonin and SERT to diagnose autism severity PMID: 29738009
  12. Findings indicated that the SERT insertion/deletion polymorphism may serve as a genetic biomarker of irritable bowel syndrome in Asians and Caucasians. [meta-analysis] PMID: 30121382
  13. results showing strong associations of childhood neglect and abuse and significant effects of the low-expressing alleles (S; L G ) of 5-HTTLPR with alexithymia. PMID: 29306941
  14. Alcohol use may be positively related, at least cross-sectionally, to depressive symptoms in female carriers of the 5-HTTLPR S allele, and indicate that moderators such as SLC6A4 genotype and sex need to be taken into account when examining associations between depressive symptoms and drinking behavior. PMID: 29220746
  15. The SERT gene promoter SNP rs25531 was associated with the cancer-related fatigue in patients with colon and rectal cancer PMID: 29551185
  16. No differences were found between murderers and thieves either concerning 5HTTLPR and 5-HT2C genotypes or concerning psychological measures. Comparison of polymorphism distribution between groups of prisoners and controls revealed highly significant associations of 5HTTLPR and 5-HTR2C (rs6318) gene polymorphisms with being convicted for criminal behavior. PMID: 29621775
  17. Significant association was observed between the S/S genotype of the SLC6A4 polymorphism and globus pharyngeus, suggesting that SLC6A4 is a potential candidate gene involved in the pathogenesis of globus pharyngeus. PMID: 29310115
  18. Association of SLC6A4 variants with familial form of OCD. PMID: 28691545
  19. 5-HTTLPR genotype was associated with traffic behaviour: The S'-allele carriers had significantly lower odds for speeding offences and traffic accidents. The lower prevalence of S'-allele carriers among those who had committed speeding offences was statistically significant in females, while the lower prevalence of having been involved in a traffic accident was rather observed in males. PMID: 29407665
  20. In the present study we systematically investigated the contribution of SNPs toward Social anxiety disorder by performing genotyping of 24 SNPs that have been reported previously in SAD or other psychiatric disorders. This showed an association between rs140701 at SLC6A4 and SAD, especially in Social anxiety disorder patients without panic disorder. PMID: 28272115
  21. Functional network-based phenotype links genetic variation in 5-HTTLPR to emotion regulation. PMID: 28589968
  22. These findings indicate that TPH1, TPH2, and SLC6A4 variants moderate the subjective effects of cocaine in non-treatment-seeking cocaine-dependent participants. PMID: 28590957
  23. This study found that the SLC6A4 hyper-methylation and hypo-expression was found in healthy subjects with childhood trauma. PMID: 29056292
  24. resilience fully mediated the association between the S 5-HTTLPR allele and depression in the medically ill. PMID: 28903099
  25. Study applied graph theory analysis on resting-state fMRI of 120 women selected based on neuroticism score, & genotyped 2 polymorphisms: 5-HTTLPR (S-carriers and L-homozygotes) and COMT (rs4680-rs165599; COMT risk group and COMT non-risk group). For the 5-HTTLPR polymorphism, found that subnetworks related to cognitive control show less connections with other subnetworks in S-carriers compared to L-homozygotes. PMID: 27743374
  26. The nursing diagnoses of risk for suicide and imbalanced nutrition are reported less often in 5-HTTLPR homozygotes of the high-expressing gene (LA). Carriers of the low-expressing genes (LG or S) have a worse response to interventions which aim to increase low self-esteem, indicating that they may need more intensive care in order to achieve the desired outcome. PMID: 29016262
  27. Pilot study demonstrated an increase in the SLC6A4 promoter DNA methylation levels in the saliva of children and adolescents with obsessive-compulsive disorder. DNA methylation provides one important epigenetic mechanism through which environmental influences can affect psychiatric disease risk. PMID: 29102815
  28. genetic association studies in population in Spain: Data suggest genetic polymorphisms in SLC6A4 promoter region are associated with ability to control food intake in overweight/obese subjects while in weight loss programs; SLC6A4 promoter polymorphisms interact with emotional eating to modulate weight loss. The biggest challenge for losing weight is the ability to control the amount of food eaten. PMID: 28766852
  29. findings suggest that the 5-HTTLPR S allele is associated with lower BMD in adults younger than 50 years PMID: 28892067
  30. Depression remitted 5-HTTLPR S/Lg-carriers who experienced childhood trauma automatically avoided sad facial expressions relatively more than LaLa homozygotes with childhood trauma. Remitted LaLa-carriers who had not experienced childhood trauma, avoided sad faces relatively more than LaLa homozygotes with childhood trauma. Study did not find a main effect of childhood trauma. PMID: 29547643
  31. In a study of the genetic association between polymorphisms in the DAT1, SERT, COMT and BDNF genes and attention deficit and hyperactive disorder, transmission disequilibrium test analysis showed that no individual allele of any variant studied has a preferential transmission PMID: 29122229
  32. Participants who assessed themselves with greater interdependence reported lower death anxiety/depression and showed decreased neural response to death-related words in emotion-related brain regions including the anterior cingulate, putamen, and thalamus. However, these results were evident in long/long allele carriers of the 5-HTTLPR but not in short/short allele carriers. PMID: 28921740
  33. 5-HTTLPR S-allele carriers showed a more negative relation between stress exposure and connectivity of the executive control network than L-allele homozygotes, specifically in the pre/postcentral gyrus, striatum, and frontal pole. In the default mode network, found a positive association between the GxE and supramarginal gyrus connectivity. PMID: 27738993
  34. Study found a significant interaction effect of the serotonin transporter-linked polymorphic region (5-HTTLPR) and the polymorphism in the serotonin 1A receptor gene (rs6295) on the connectivity within the right frontoparietal network, specifically in the middle frontal gyrus and inferior parietal lobule. Mean connectivity in the right inferior parietal lobule was positively correlated with working memory performance. PMID: 28793232
  35. SIDS is associated with peripheral abnormalities in the 5-HT pathway: compared with postmortem infant SIDS and postmortem infant control samples, living infant controls had higher concentrations of serum 5-HT and lower concentrations of 5-HIAA PMID: 28674018
  36. Findings support the relevance of peripheral SLC6A4 promoter DNA methylation for frontal-limbic brain processes in healthy individuals, and provided some support for convergence across blood, saliva and epithelial tissues. Buccal epithelial cells may be most sensitive surrogate samples in DNA methylation studies to detect frontal-limbic brain associations. PMID: 28774705
  37. The 5-HTTLPR polymorphism was associated with the rate of achievement of remission and tolerability of treatment: carriers of the SS genotype achieved remission less frequently and more frequently experienced side-effects. PMID: 27029447
  38. A significant 5-HTTLPRxearly adversity interaction indicated that greater early adversity was associated with lower latent trait cortisol levels, but only among individuals with either L/L or S/L genotype. Findings suggest that serotonergic genetic variation may influence the impact of early adversity on individual differences in hypothalamic-pituitary-adrenal axis regulation. PMID: 28757071
  39. 5-HTTLPR and childhood adversity are associated with the personality trait openness to experience. PMID: 28800511
  40. These data suggest that the carriage of the short form of the 5-HTTLPR may negate the protective effect of psychological resilience against in patient wit depression. PMID: 28774788
  41. Study shows that individuals homozygous for the long allele of the 5-HTTLPR gene respond to stressful events by reappraising their emotional meaning, which may hamper the harmful effect of stress on mental health. PMID: 28901577
  42. The 5-HTTLPR polymorphism was associated with neuroticism in women with Premenstrual Dysphoric Disorder. There is more evidence for a role of SERT polymorphisms in Postpartum Depression. PMID: 29082433
  43. Study suggests that epigenetic mechanisms rather than 5-HTTLPR alone influence in vivo human serotonin transporter (5-HTT) availability. PMID: 28675387
  44. SERT binding in the diencephalon is reduced in insulin-resistant subjects independently of body weight, while hypothalamic SERT binding tends to be lower in obesity, with no difference between insulin-resistant and insulin-sensitive subjects. This suggests that the metabolic perturbations associated with obesity independently affect SERT binding within the diencephalon. PMID: 27626923
  45. The current meta-analysis provides new evidence for the robustness of the interaction between stress and 5-HTTLPR in depression. PMID: 29031184
  46. Serotonin transporter (5-HTT) is responsible for removing serotonin from the synaptic cleft, returning it to the presynaptic neuron, thereby determining the extent, duration and spatial domain of the serotonergic activation. PMID: 26860734
  47. Study found that S-carriers, relative to LL-homozygous individuals, showed increased magnetoencephalography gamma band power within the amygdala for the late amygdala response to fearful expressions (i.e., after information had been processed within superior temporal sulcus) and not for the early response. PMID: 28580622
  48. It is unlikely that the investigated genetic variants are clinically relevantly associated with depression after diagnosis of cancer. PMID: 28590587
  49. Studied association of aggression and 5-HTTLPR, 5HTR1A, and 5HTR2A genetic polymorphisms in industrial Russian and traditional Tanzanian population groups. PMID: 29661255
  50. the allelic distribution of solute carrier family-6 member-4 promoter region in Turkish athletes, is reported. PMID: 28719342

Show More

Hide All

Subcellular Location
Cell membrane; Multi-pass membrane protein. Endomembrane system; Multi-pass membrane protein. Endosome membrane; Multi-pass membrane protein. Cell junction, synapse. Cell junction, focal adhesion.
Protein Families
Sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family, SLC6A4 subfamily
Tissue Specificity
Expressed in platelets (at protein level).
Database Links

HGNC: 11050

OMIM: 103780

KEGG: hsa:6532

STRING: 9606.ENSP00000261707

UniGene: Hs.134662

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*